If serum HA concentration is significantly increased in prostate cancer patients compared to non-cancer counterparts as demonstrated herein, it could be a useful tool to help identify patients at risk of harboring prostate cancer, either by adding PSA to routine screening or helping to select patients for re-biopsy. Here, KLK3 is linked to prostate carcinoma.